Lexicon Pharmaceuticals, Inc.

Ownership Transactions Reported by 30 Insiders

Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2445 Technology Forest Blvd., Suite 1100, The Woodlands, TX

There are no Buy or Sell transactions made by insiders since 10/6/2024

Lexicon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Artal International S.C.A. Director, 10%+ Owner $357M May 10, 2024
Siren, L.L.C. Director, 10%+ Owner $92.8M Jul 25, 2024
Artal Participations S.a r.l. Director, 10%+ Owner $91.2M Dec 5, 2024
Raymond Debbane Director $23.4M Jun 3, 2025
Invus US Partners LLC Director, 10%+ Owner $6.09M Aug 5, 2022
Lonnel Coats Chief Executive Officer, Director $3.51M Feb 28, 2024
Jeffrey L. Wade President and COO $1.11M Jul 8, 2024
Michael Exton Chief Executive Officer, Director $1.01M Feb 13, 2025
Kenneth B. Kassler-Taub SVP, Regulatory & QA $598K Feb 28, 2024
Brian T. Crum SVP, General Counsel & Secr. $350K Feb 28, 2025
Scott M. Coiante SVP, Chief Financial Officer $322K Feb 13, 2025
Alan J. Main EVP, Innov & Chem Sciences $319K Feb 28, 2025
Brian Corrigan SVP, Regulatory & QA $301K Feb 13, 2025
Philippe Amouyal Director $242K Jun 3, 2025
Thomas Garner SVP, Chief Commercial Officer $239K Feb 8, 2024
Robert J. Lefkowitz Director $223K May 13, 2024
Christopher J. Sobecki Director $200K Jun 3, 2025
Craig B. Granowitz SVP, Chief Medical Officer $180K Feb 28, 2025
L. Barker Director $160K Jun 3, 2025
Wendy McDermott SVP, Human Resources $152K Feb 28, 2025
Judith L. Swain Director $140K Jun 3, 2025
Diane E. Sullivan Director $115K Jun 3, 2025
Kiernan Seth VP, Chief Commercial Officer $104K Feb 28, 2023
Kristen Alexander VP, Finance and Accounting $77.8K Feb 28, 2025
Suma Gopinathan SVP, Discovery $46.9K Jun 1, 2025
Lisa DeFrancesco SVP, IR and Corp Comm $43.5K Feb 28, 2025
Alan S. Nies Director $43.2K May 21, 2023
Frank Palantoni Director $42.5K May 21, 2023
Rachel Y. Martens VP, Partnerships & Corp Strat $0 Jun 1, 2025
Ivan Cheung Director Jun 3, 2025

Recent Insider Transactions by Companies or Individuals for Lexicon Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.